Press release content from Business Wire. The AP news staff was not involved in its creation. $1.3 Billion Worldwide Myasthenia Gravis Drugs Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets.com April 6, 2021 GMT DUBLIN--(BUSINESS WIRE)--Apr 6, 2021-- Amid the COVID-19 crisis, the global market for Myasthenia Gravis Drugs estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$2.3 Billion by 2027, growing at a CAGR of 8.7% over the analysis period 2020-2027. ADVERTISEMENT Drug Treatment, one of the segments analyzed in the report, is projected to record a 9.1% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Rapid Immunotherapies segment is readjusted to a revised 6.9% CAGR for the next 7-year period.